Health - Google News: Cystic Fibrosis Data That Sent Vertex Stock Soaring Were Incorrect - Forbes

Health - Google News Google News

Cystic Fibrosis Data That Sent Vertex Stock Soaring Were Incorrect - Forbes May 30th 2012, 11:21 Proactive Investors USA & Canada Cystic Fibrosis Data That Sent Vertex Stock Soaring Were Incorrect Forbes In a preliminary, or interim, analysis of 37 patients taking the drug, Vertex had previously said that 17, or 46%, had experienced an improvement in a measure of lung function called FEV1 of 5 percentage points or more, and 11, or 30%, had experienced ... Vertex Revises Cystic Fibrosis Combo DataBloomberg Vertex Pharmaceuticals Inc. (VRTX) Dropped Sharply After Phase 2 CorrectionRTT News Vertex Overstated Efficacy Of Cystic-Fibrosis DrugWall Street Journal San Francisco Chronicle -CBS News -PMLiVE all 87 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: